We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UP:NYSEWheels Up Experience Inc. Analysis

Data as of 2026-05-07 - not real-time

$6.62

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Wheels Up is trading at $6.62, well below its 20‑day SMA of $7.32 and far under the 200‑day SMA of $21.93, confirming a sustained bearish trend. The RSI at 43.3 indicates the stock is not yet oversold, while the MACD shows a marginal bullish crossover (line -1.08 above signal -1.11) with a tiny positive histogram, suggesting only fleeting upward momentum. Volatility is extreme at 178% over the past 30 days and beta exceeds 2.0, meaning the share price swings wildly and is highly sensitive to market moves. Fundamentally, the company posted a 10% revenue decline, negative gross (14.3%) and operating margins (‑28.8%), and a massive net loss (‑$399 M) with a trailing EPS of ‑8.4, leaving cash at $134 M against $473 M of debt and a negative book value per share. Recent material news adds pressure: a law‑firm investigation into shareholder losses and a planned 20‑for‑1 reverse stock split signal distress and potential dilution. Together, the technical weakness, deteriorating fundamentals, high risk metrics, and adverse news create a highly precarious investment case.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Pending 20‑for‑1 reverse split likely to trigger price volatility
  • Legal investigation increasing uncertainty
  • Extreme short‑term volatility and bearish technical positioning

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Upcoming Q1 earnings could reveal any operational improvements
  • Continued negative cash flow and high debt limit upside
  • Market sentiment (Extreme Greed) may be unsustainable for a distressed stock

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Structural profitability challenges with negative margins and losses
  • High beta and historical 92% drawdown indicate poor downside protection
  • Lack of dividend and no clear path to positive cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth-10.20%
Profit Margin-39.95%
P/E Ratio-1.1
ROA-13.42%
P/B Ratio-12.2
Op. Cash Flow$-166295008
Free Cash Flow$-191762496
Industry P/E30.1

Technical Analysis

TrendBearish
RSI43.3
Support$4.69
Resistance$10.94
MA 20$7.32
MA 50$9.28
MA 200$21.93
MACDBullish
VolumeIncreasing
Fear & Greed Index90.93

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta2.41
Volatility178.05%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.